Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
29 Oct 2024 |
CS01 |
Confirmation statement made on 18 August 2024 with updates
|
|
|
29 Oct 2024 |
PSC01 |
Notification of Ashwin Prafulchandra Patel as a person with significant control on 29 October 2024
|
|
|
29 Oct 2024 |
PSC07 |
Cessation of Ameer Singh Bahl as a person with significant control on 29 October 2024
|
|
|
29 Oct 2024 |
TM01 |
Termination of appointment of Ameer Singh Bahl as a director on 29 October 2024
|
|
|
29 Oct 2024 |
TM01 |
Termination of appointment of Dawn Pharma Group Ltd as a director on 29 October 2024
|
|
|
03 Jun 2024 |
AD01 |
Registered office address changed from 156 Cromwell Road Kensington London -- Select State -- SW7 4EF United Kingdom to 156 Cromwell Road 1st Floor London Uk SW7 4EF on 3 June 2024
|
|
|
15 Mar 2024 |
AA |
Accounts for a dormant company made up to 31 July 2023
|
|
|
21 Nov 2023 |
AP01 |
Appointment of Mr Ashwin Patel as a director on 17 November 2023
|
|
|
26 Oct 2023 |
CS01 |
Confirmation statement made on 18 August 2023 with updates
|
|
|
18 Aug 2023 |
AP01 |
Appointment of Mr Ameer Singh Bahl as a director on 7 August 2023
|
|
|
18 Aug 2023 |
CH02 |
Director's details changed for Dawn Pharma Group Ltd on 1 August 2023
|
|
|
18 Aug 2023 |
PSC04 |
Change of details for Mr Ameer Singh Bahll as a person with significant control on 21 February 2023
|
|
|
31 Mar 2023 |
AD01 |
Registered office address changed from Beadle House C/O Project H Ltd Bull Plain Hertford Hertfordshire SG14 1DT United Kingdom to 156 Cromwell Road Kensington London -- Select State -- SW7 4EF on 31 March 2023
|
|
|
21 Feb 2023 |
PSC01 |
Notification of Ameer Singh Bahll as a person with significant control on 21 February 2023
|
|
|
21 Feb 2023 |
PSC07 |
Cessation of Dawn Pharma Group Ltd as a person with significant control on 21 February 2023
|
|
|
21 Feb 2023 |
AA |
Total exemption full accounts made up to 31 July 2022
|
|
|
22 Jan 2023 |
AD01 |
Registered office address changed from 97-98 First Floor, Lansdowne House, 57 Berkeley Square London W1J 6ER to Beadle House C/O Project H Ltd Bull Plain Hertford Hertfordshire SG14 1DT on 22 January 2023
|
|
|
22 Jan 2023 |
AA01 |
Previous accounting period extended from 30 April 2022 to 31 July 2022
|
|
|
18 Aug 2022 |
PSC07 |
Cessation of Kk Global Marketing Limited as a person with significant control on 18 August 2022
|
|
|
18 Aug 2022 |
PSC02 |
Notification of Dawn Pharma Group Ltd as a person with significant control on 18 August 2022
|
|
|
18 Aug 2022 |
CS01 |
Confirmation statement made on 18 August 2022 with updates
|
|
|
18 Aug 2022 |
TM01 |
Termination of appointment of Karim Kalaf as a director on 18 August 2022
|
|
|
18 Aug 2022 |
AP02 |
Appointment of Dawn Pharma Group Ltd as a director on 18 August 2022
|
|
|
13 Jul 2022 |
CS01 |
Confirmation statement made on 1 July 2022 with no updates
|
|
|
09 Feb 2022 |
AA |
Accounts for a dormant company made up to 30 April 2021
|
|